Ocular Lymphangiogenesis
Ocular Lymphangiogenesis
批准号:
7590207
负责人:
DANIEL J CARR
金额:
$18.21万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-01 至 2010-12-31
关键词:
AcuteAddressAntibodiesAntigensBindingBlood VesselsC57BL/6 MouseCellsCervical lymph node groupCorneaDevelopmentDextransDichloromethylene DiphosphonateDiseaseDrainage procedureEducationEffector CellEngraftmentEpithelial CellsEventGenerationsGoalsGrowthHerpesvirus 1Herpetic KeratitisImmune responseInbred BALB C MiceInfectionInflammationInterleukin-6KeratitisKeratoplastyLigandsLiposomesLymphLymphangiogenesisLymphaticLymphatic vesselLysineMandibleMediatingModelingMusPathway interactionsPlacental Growth FactorRoleSeveritiesSimplexvirusSpleenT-LymphocyteTestingTimeTransplantationVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVascular Endothelial Growth Factor DVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3VirusVirus DiseasesVisual Acuitydefined contributiondextrandriving forcelymph nodesmacrophagemonocyteneovascularizationneutrophilnovelpodoplaninpublic health relevanceresponsetrafficking
中文摘要
描述(申请人提供):新生血管和淋巴管生成是通常由于炎症而在正常的无血管角膜中发生的不良事件。因此,视力可能会受到损害,在感染的情况下,通过引流淋巴结内效应细胞的“教育”,会产生适应性免疫反应。作为对角膜病毒感染的反应,BALB/c小鼠在感染后7-10天内观察到强烈的新生血管生成反应。我们发现,在野生型(WT)C57BL/6小鼠中,急性单纯疱疹病毒1型(HSV-1)感染角膜也会发生淋巴管生成。然而,与角膜移植模型不同的是,我们发现眼部HSV-1感染后淋巴管的发育不需要单核细胞或巨噬细胞。此外,在这个眼部HSV-1感染模型中,淋巴管的生成依赖于血管内皮生长因子受体2(VEGFR2)配体,而不是涉及VEGF-A和可能的胎盘生长因子的VEGF受体3配体。这是角膜淋巴管生成的独一无二的发现,也是我们想要研究的。具体地说,我们想检验这样一个假设,即HSV-1介导的淋巴管生成是通过HSV-1感染的上皮细胞表达VEGF-A而发生的,所产生的淋巴管是有功能的,并有助于产生对HSV-1的获得性免疫反应。为了检验这一假设,提出了两个特定的目标:特定的目标1将通过识别纵向表达VEGF-A的细胞来研究VEGF-A在病毒诱导的淋巴管生成中的作用,确定参与VEGF-A表达的机制,并定义其他因素(例如,IL-6,VEGF-C,和血管内皮生长因子D)对HSV-1感染后淋巴管生成的影响。具体目标2将通过确定感染后从角膜到引流淋巴结的细胞来解决新产生的淋巴管的功能,并确定从HSV-1感染的小鼠获得的表达或不表达角膜淋巴管的淋巴结细胞的抗原驱动反应。为了实现这些目标,我们应该避开驱动HSV-1诱导的角膜淋巴管生成的因素的作用,并确定淋巴管在产生对随后的基质角膜炎至关重要的获得性免疫反应中的作用。公共卫生相关性与淋巴管生成相关机制的识别(S)可能会突出新的分子/途径,这些分子/途径对淋巴管的发育以及它们对适应性免疫反应的发展都有重要的贡献。由于T细胞与间质角膜炎的发生和严重程度有关,识别影响效应性T细胞发育的其他途径可能为抑制疾病和保持视力提供靶点。
英文摘要
DESCRIPTION (provided by applicant): Neovascularization and lymphangiogenesis are undesirable events that often transpire in the normally avascular cornea as a result of inflammation. As a consequence, visual acuity can be compromised and in the case of infection, an adaptive immune response ensues through the "education" of effector cells within the draining lymph nodes. In response to virus infection of the cornea, a strong angiogenic response has been noted with new blood vessel growth within 7-10 days post infection in BALB/c mice. We have found lymphangiogenesis also occurs in response to acute herpes simplex virus type 1 (HSV-1) infection of the cornea in wild type (WT) C57BL/6 mice. However, unlike the corneal transplant model, we have found lymphatic vessel development in response to ocular HSV-1 infection does not require monocyte or macrophages. Furthermore, in this model of ocular HSV-1 infection lymphangiogenesis is dependent on vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) ligands but not VEGF receptor 3 ligands implicating VEGF-A and possibly placental growth factor. This is a unique finding for lymphangiogenesis in the cornea and one we wish to pursue. Specifically, we would like to test the hypothesis that HSV-1-mediated lymphangiogenesis occurs thru VEGF-A expression by HSV-1-infected epithelial cells and the lymphatic vessels created are functional and contribute to the generation of the adaptive immune response to HSV- 1. In order to test the hypothesis, two specific aims are proposed: Specific aim 1 will address the role of VEGF-A in virus-induced lymphangiogenesis by identifying the cells that express VEGF-A longitudinally, determine the mechanism involved in VEGF-A expression, and define the contribution of other factors (e.g., IL-6, VEGF-C, and VEGF- D) to lymphangiogenesis following HSV-1 infection. Specific aim 2 will address the functionality of the newly created lymphatic vessels by identifying the cells that traffic from the cornea to the draining lymph nodes at times post infection and determine the antigen-driven response of lymph node cells obtained from HSV-1-infected mice that either do or don't express corneal lymph vessels. In accomplishing these goals, we should eludicate the contribution of factors that drive HSV-1-induced corneal lymphangiogenesis and define the role of the lymphatic vessels in the generation of the adaptive immune response critical for ensuing stromal keratitis. PUBLIC HEALTH RELEVANCE The identification of mechanism(s) associated with lymphangiogenesis may highlight novel molecules/pathways that significantly contribute to the development of lymphatic vessels as well as their contribution to the development of the adaptive immune response. Since T cells are associated with the development and severity of stromal keratitis, the identification of additional pathways that influence the development of effector T cells may provide targets to suppress the disease and preserve visual acuity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular & Molecular Cascades in Vision Research
-
批准号:8853282
-
项目类别:
-
资助金额:$14.2万
-
财政年份:2014
-
负责人:DANIEL J CARR
-
依托单位:
Cellular & Molecular Cascades in Vision Research
-
批准号:8662545
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2014
-
负责人:DANIEL J CARR
-
依托单位:
Genotyping Core
-
批准号:10011812
-
项目类别:
-
资助金额:$11.49万
-
财政年份:2011
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8386499
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8922184
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8025043
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8585853
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8204539
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:9181424
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Ocular Lymphangiogenesis
-
批准号:7744640
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2009
-
负责人:DANIEL J CARR
-
依托单位:
The Role of CXCL9 in Genital HSV-2 Infection
-
批准号:7624586
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2007
-
负责人:DANIEL J CARR
-
依托单位:
The Role of CXCL9 in Genital HSV-2 Infection
-
批准号:7457966
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2007
-
负责人:DANIEL J CARR
-
依托单位:
The Role of CXCL9 in Genital HSV-2 Infection
-
批准号:7305579
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2007
-
负责人:DANIEL J CARR
-
依托单位:
Anti-Viral Gene Delivery in the Nervous System
-
批准号:6757751
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2004
-
负责人:DANIEL J CARR
-
依托单位:
Anti-Viral Gene Delivery in the Nervous System
-
批准号:6875563
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2004
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:7393823
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:8286147
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:6556505
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:6877705
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:6727496
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
海外基金